• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杜普伊特伦挛缩症的临床表现及类型。

Clinical presentation and types of Dupuytren's disease.

作者信息

Rayan G M

机构信息

Department of Orthopedic Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

出版信息

Hand Clin. 1999 Feb;15(1):87-96, vii.

PMID:10050245
Abstract

The clinical presentation of Dupuytren's disease is discussed with emphasis on dermato-pathology, the nodule, the cord, ectopic manifestations regional and distant, and disease progression. The differential diagnosis also is described with a list of pseudo-Dupuytren's disease cases. Observations by this author suggest that there are two distinct clinical entities responsible for palmar fascial contracture, namely typical Dupuytren's disease and atypical Dupuytren's contracture. These two types seem to differ in presentation, treatment, and prognosis. The characteristic clinical findings of each of these two types are described. The disparity among treatment outcome studies and epidemiologic studies with regard to the prevalence of Dupuytren's disease is probably in part due to lack of distinction between these two clinical types. Accurate diagnosis and satisfactory treatment outcome can be achieved by careful history, thorough physical examination, and keen understanding of the pathophysiology of this enigmatic disease.

摘要

本文讨论了杜普伊特伦挛缩病的临床表现,重点介绍了皮肤病理学、结节、条索、局部和远处的异位表现以及疾病进展。还描述了鉴别诊断,并列举了假性杜普伊特伦挛缩病病例。作者的观察表明,有两种不同的临床实体可导致掌腱膜挛缩,即典型的杜普伊特伦挛缩病和非典型的杜普伊特伦挛缩。这两种类型在表现、治疗和预后方面似乎有所不同。文中描述了这两种类型各自的特征性临床发现。治疗结果研究和流行病学研究在杜普伊特伦挛缩病患病率方面存在差异,这可能部分是由于未能区分这两种临床类型。通过仔细询问病史、全面的体格检查以及对这种疑难疾病病理生理学的深入理解,可以实现准确诊断和满意的治疗效果。

相似文献

1
Clinical presentation and types of Dupuytren's disease.杜普伊特伦挛缩症的临床表现及类型。
Hand Clin. 1999 Feb;15(1):87-96, vii.
2
Non-Dupuytren's disease of the palmar fascia.掌腱膜的非杜普伊特伦病
J Hand Surg Br. 2005 Dec;30(6):551-6. doi: 10.1016/j.jhsb.2005.08.004. Epub 2005 Oct 3.
3
Palmar fascial complex anatomy and pathology in Dupuytren's disease.掌腱膜复合体在杜普伊特伦挛缩病中的解剖与病理
Hand Clin. 1999 Feb;15(1):73-86, vi-vii.
4
Dupuytren's palmar contracture in women.女性掌腱膜挛缩症
Isr Med Assoc J. 2008 Jun;10(6):445-7.
5
Is Dupuytren's disease caused by an imbalance between proliferation and cell death?掌腱膜挛缩症是由增殖与细胞死亡之间的失衡引起的吗?
J Hand Surg Br. 1999 Oct;24(5):511-4. doi: 10.1054/jhsb.1999.0251.
6
A retrospective review of the management of Dupuytren's nodules.一项关于掌腱膜结节治疗的回顾性研究。
J Hand Surg Am. 2005 Sep;30(5):1014-8. doi: 10.1016/j.jhsa.2005.03.005.
7
A clinical analysis of Dupuytren's disease of the thumb.拇指掌腱膜挛缩症的临床分析
J Hand Surg Eur Vol. 2008 Jun;33(3):272-9. doi: 10.1177/1753193408087025.
8
Gelatinase A activity in Dupuytren's disease.杜普伊特伦挛缩症中的明胶酶A活性
J Hand Surg Am. 2006 Dec;31(10):1635-9. doi: 10.1016/j.jhsa.2006.08.007.
9
Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.掌腱膜挛缩症中的表皮生长因子受体(EGF-R)
J Hand Surg Br. 2005 Dec;30(6):570-3. doi: 10.1016/j.jhsb.2005.06.008. Epub 2005 Aug 2.
10
Dupuytren's disease: anatomy, pathology, presentation, and treatment.
Instr Course Lect. 2007;56:101-11.

引用本文的文献

1
Surgical treatment results for dupuytren's disease.掌腱膜挛缩症的手术治疗结果。
Acta Ortop Bras. 2017 May-Jun;25(3):71-73. doi: 10.1590/1413-785220172503164827.
2
Systematic review of non-surgical treatments for early dupuytren's disease.早期掌腱膜挛缩症非手术治疗的系统评价
BMC Musculoskelet Disord. 2016 Aug 15;17(1):345. doi: 10.1186/s12891-016-1200-y.
3
WT1 expression is increased in primary fibroblasts derived from Dupuytren's disease tissues.在源自杜普伊特伦挛缩症组织的原代成纤维细胞中,WT1表达增加。
J Cell Commun Signal. 2015 Dec;9(4):347-52. doi: 10.1007/s12079-015-0293-7. Epub 2015 Jun 30.
4
Developing an animal model of Dupuytren's disease by orthotopic transplantation of human fibroblasts into athymic rat.通过将人成纤维细胞原位移植到无胸腺大鼠体内建立掌腱膜挛缩症的动物模型。
BMC Musculoskelet Disord. 2015 Jun 7;16:138. doi: 10.1186/s12891-015-0597-z.
5
Clinical outcomes following collagenase injections compared to fasciectomy in the treatment of Dupuytren's contracture.与筋膜切除术相比,胶原酶注射治疗掌腱膜挛缩症后的临床疗效。
Hand (N Y). 2015 Jun;10(2):260-5. doi: 10.1007/s11552-014-9704-0.
6
Operative trends and physician treatment costs associated with Dupuytren's disease in Canada.加拿大与掌腱膜挛缩症相关的手术趋势及医生治疗费用
Can J Plast Surg. 2013 Winter;21(4):229-33.
7
Association among work exposure, alcohol intake, smoking and Dupuytren's disease in a large cohort study (GAZEL).一项大型队列研究(GAZEL)中工作暴露、酒精摄入、吸烟与杜普伊特伦挛缩病之间的关联
BMJ Open. 2014 Jan 29;4(1):e004214. doi: 10.1136/bmjopen-2013-004214.
8
Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease.利用外显子芯片进行全基因组分析表明,细胞外基质表达、纤维化控制和组织重塑基因在杜普伊特伦挛缩症中具有重要作用。
PLoS One. 2013;8(3):e59056. doi: 10.1371/journal.pone.0059056. Epub 2013 Mar 12.
9
Current trends in the surgical management of Dupuytren's disease in Europe: an analysis of patient charts.欧洲掌腱膜挛缩症手术治疗的当前趋势:患者病历分析
Eur Orthop Traumatol. 2012 Mar;3(1):31-41. doi: 10.1007/s12570-012-0092-z. Epub 2012 Mar 6.
10
Dupuytren's Disease: Review of the Current Literature.杜普伊特伦挛缩症:当前文献综述
Open Orthop J. 2011;5 Suppl 2:283-8. doi: 10.2174/1874325001105010283. Epub 2011 Jul 28.